Logo Mettler Toledo

Mettler Toledo (MTD) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Mettler Toledo · Health Care · ref. ETF XLV · 50 calls · price $1598.03
🔔Price alertsCreate an alert →
What the company does: Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

📈 Mettler Toledo (MTD) stock price

$1598.03+22.6% over range
Oct 14, 25low $1025.53 · high $1598.03Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
45% recommend buying · 11 analysts
📊 JPI status : Mettler Toledo has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 MTD price target & analyst consensus — price $1,598

The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$1700+6.4%
Median target · of 11 targets$1507.5-5.7%
Lowest target · 1 firm of 11$1194-25.3%
Current price$1598.03
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 218% $1600 ↔ $1700
Below 982% $1194 ↔ $1580
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Jefferies — 72% of its targets hit on this sector (383 calls tested). It aims for $1,580 (-1.1 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).

The 5 reliable analysts $1,580-1.1 %
The 6 other firms $1,358-15 %
How to read it: the 5 reliable firms are not filtered by optimism — 2 aim above the price, 3 below, hence their $1,580 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy545%
Hold545%
Sell19%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Mettler Toledo? The JPI assistant answers using our backtest data.

📈 Mettler Toledo fundamentals: valuation, margins & growth › open the full page

P/E 35.2Net margin 21.9 %Revenue growth +4.5 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 22 %
2023
Rev −3%Profit −10%
2024
Rev +2%Profit +9%
2025
Rev +4%Profit +1%

🔎 Detailed analyses

✅ Historical analyst reliability on MTD

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Cantor Fitzgerald ↗ 100% +27.6% 3
Jefferies ↗ 100% +25.2% 3
Citigroup ↗ 83% +10.1% 6
Evercore ISI Group ↗ 83% -2.5% 6
B of A Securities ↗ 80% +22.9% 5
Wells Fargo ↗ 50% +0.3% 6
Barclays ↗ 50% -8.6% 4
UBS ↗ 43% -16.4% 7
Stifel ↗ 40% -0.5% 5
Goldman Sachs ↗ 33% -0.7% 3

📊 What $1,000 invested in Mettler Toledo would be worth › open the full page

In short — $1,000 invested in Mettler Toledo 10 years ago would be worth $3,767 today, i.e. +14%/yr on average. Best year: 2021 (+49%), worst: 2023 (-16%). Price performance, excluding dividends.

If I'd invested $1,000 in Mettler Toledo

InvestmentWorth todayGain
1 years ago$1,044+4%
3 years ago$884-12%
5 years ago$1,121+12%
→ See Mettler Toledo's full return history + gain calculator

Return by year (Mettler Toledo)

YearReturn$1,000 invested at year start
2026 (YTD)-8%$916 (-8%)
2025+14%$1,044 (+4%)
2024+1%$1,053 (+5%)
→ See Mettler Toledo's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Mettler Toledo

Loading news…

📋 All analyst calls on MTD

Morgan Stanley ↗
Oct 13, 26
■ Equal-Weight neutral · not a buy · 🎯$1575
Today : $1598.03 — gap to target -1%
🎯 on MTD : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 13, 27
Barclays ↗
Oct 7, 26
▲ Overweight · 🎯$1700
Price at call : $1529.46 — upside +11%
Today : $1598.03 — upside +6%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
▼ Sell · 🎯$1200
Price at call : $1367.74 — upside -12%
Today : $1598.03 — upside -25%
🎯 on MTD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 2, 27
RBC Capital ↗
Sep 1, 26
■ Sector Perform neutral · not a buy · 🎯$1515
Price at call : $1375.96 — gap to target +10%
Today : $1598.03 — gap to target -5%
🎯 on MTD : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 1, 27
■ Equal-Weight neutral · not a buy · 🎯$1450
Price at call : $1437 — gap to target +1%
Today : $1598.03 — gap to target -9%
🎯 on MTD : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 4, 27
▲ Outperform · 🎯$1500
Price at call : $1437 — upside +4%
Today : $1598.03 — upside -6%
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 3, 27
Wells Fargo ↗
Aug 3, 26
■ Equal-Weight neutral · not a buy · 🎯$1450
Price at call : $1437 — gap to target +1%
Today : $1598.03 — gap to target -9%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 3, 27
Barclays ↗
Aug 3, 26
▲ Overweight · 🎯$1575
Price at call : $1445 — upside +9%
Today : $1598.03 — upside -1%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 3, 27
See the other 42 calls, newest to oldest
Stifel ↗
Aug 3, 26
▲ Buy · 🎯$1600
Price at call : $1445 — upside +11%
Today : $1598.03 — upside +0%
🎯 on MTD : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 3, 27
Jefferies ↗
Jul 31, 26
▲ Buy · 🎯$1580
Price at call : $1445 — upside +9%
Today : $1598.03 — upside -1%
🎯 on MTD : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jul 31, 27
▲ Outperform · 🎯$1350
Price at call : $1295.59 — upside +4%
Today : $1598.03 — upside -16%
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
Stifel ↗
May 18, 26
▲ Buy · 🎯$1400
Price at call : $1050.77 — upside +33%
Today : $1598.03 — upside -12%
🎯 on MTD : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : May 18, 27
Morgan Stanley ↗
May 12, 26
■ Equal-Weight neutral · not a buy · 🎯$1275
Price at call : $1025.53 — gap to target +24%
Today : $1598.03 — gap to target -20%
🎯 on MTD : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : May 12, 27
JP Morgan ↗
May 11, 26
■ Neutral neutral · not a buy · 🎯$1200
Price at call : $1072.45 — gap to target +12%
Today : $1598.03 — gap to target -25%
🎯 on MTD : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : May 11, 27
Baird ↗
May 11, 26
■ Neutral neutral · not a buy · 🎯$1194
Price at call : $1078.53 — gap to target +11%
Today : $1598.03 — gap to target -25%
🎯 on MTD : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : May 11, 27
Citigroup ↗
May 8, 26
▲ Buy · 🎯$1550
Price at call : $1078.53 — upside +44%
Today : $1598.03 — upside -3%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 8, 27
Barclays ↗
Apr 14, 26
▲ Overweight · 🎯$1500
Price at call : $1315.85 — upside +14%
Today : $1598.03 — upside -6%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 14, 27
▲ Outperform · 🎯$1425
Price at call : $1270 — upside +12%
Today : $1598.03 — upside -11%
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
Jefferies ↗
Mar 20, 26
▲ Buy · 🎯$1450
Price at call : $1239.07 — upside +17%
Today : $1598.03 — upside -9%
🎯 on MTD : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Mar 20, 27
Morgan Stanley ↗
Feb 10, 26
■ Equal-Weight neutral · not a buy · 🎯$1475
Price at call : $1392.65 — gap to target +6%
Today : $1598.03 — gap to target -8%
🎯 on MTD : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Feb 10, 27
Barclays ↗
Dec 15, 25
▲ Overweight · 🎯$1550
Price at call : $1386.45 — upside +12%
Today : $1598.03 — upside -3%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 15, 26
Wells Fargo ↗
Dec 15, 25
■ Equal-Weight neutral · not a buy · 🎯$1450
Price at call : $1386.45 — gap to target +5%
Today : $1598.03 — gap to target -9%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 15, 26
Goldman Sachs ↗
Dec 9, 25
■ Neutral neutral · not a buy · 🎯$1475
Price at call : $1371.42 — gap to target +8%
Today : $1598.03 — gap to target -8%
🎯 on MTD : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 9, 26
■ Equal-Weight neutral · not a buy · 🎯$1550
Price at call : $1434.88 — gap to target +8%
Today : $1598.03 — gap to target -3%
🎯 on MTD : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
Citigroup ↗
Nov 10, 25
▲ Buy · 🎯$1700
Price at call : $1445.06 — upside +18%
Today : $1598.03 — upside +6%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Nov 10, 26
Barclays ↗
Nov 10, 25
▲ Overweight · 🎯$1600
Price at call : $1445.06 — upside +11%
Today : $1598.03 — upside +0%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Nov 10, 26
Wells Fargo ↗
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$1400
Price at call : $1432.57 — gap to target -2%
Today : $1598.03 — gap to target -12%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 10, 26
Stifel ↗
Nov 10, 25
▲ Buy · 🎯$1600
Price at call : $1432.57 — upside +12%
Today : $1598.03 — upside +0%
🎯 on MTD : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Nov 10, 26
JP Morgan ↗
Oct 9, 25
■ Neutral neutral · not a buy · 🎯$1285
Price at call : $1307.57 — gap to target -2%
Today : $1598.03 — gap to target -20%
🎯 on MTD : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Oct 9, 26
▲ Outperform · 🎯$1400
Price at call : $1328.53 — upside +5%
Today : $1598.03 — upside -12%
Expected +5% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+15.1%
stock +15% · XLV +16%
matured Oct 7, 26
Barclays ↗
Oct 2, 25
▲ Overweight · 🎯$1350
Price at call : $1314.04 — upside +3%
Today : $1598.03 — upside -16%
Expected +3% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+17.3%
stock +17% · XLV +16%
matured Oct 2, 26
■ Neutral neutral · not a buy · 🎯$1390
Price at call : $1257.03 — gap to target +11%
Today : $1598.03 — gap to target -13%
🎯 on MTD : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Sep 22, 26
Citigroup ↗
Aug 21, 25
▲ Buy · 🎯$1600
Price at call : $1321.45 — upside +21%
Today : $1598.03 — upside +0%
Expected +21% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
+5.9%
stock +6% · XLV +26%
matured Aug 21, 26
▲ Outperform · 🎯$1275
Price at call : $1243.94 — upside +2%
Today : $1598.03 — upside -20%
Expected +2% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+14.3%
stock +14% · XLV +24%
matured Aug 4, 26
Baird ↗
Aug 4, 25
■ Neutral neutral · not a buy · 🎯$1230
Price at call : $1231.88 — gap to target -0%
Today : $1598.03 — gap to target -23%
🎯 on MTD : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Aug 4, 26
Baird ↗
Jul 28, 25
■ Neutral neutral · not a buy · 🎯$1210
Price at call : $1266.1 — gap to target -4%
Today : $1598.03 — gap to target -24%
🎯 on MTD : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 28, 26
▲ Outperform · 🎯$1280
Price at call : $1206.53 — upside +6%
Today : $1598.03 — upside -20%
Expected +6% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+3.5%
stock +4% · XLV +20%
matured Jul 8, 26
■ Neutral neutral · not a buy · 🎯$1260
Price at call : $1184.54 — gap to target +6%
Today : $1598.03 — gap to target -21%
🎯 on MTD : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 26, 26
Barclays ↗
Jun 24, 25
▲ Overweight · 🎯$1325
Price at call : $1185.18 — upside +12%
Today : $1598.03 — upside -17%
Expected +12% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+1.5%
stock +2% · XLV +15%
matured Jun 24, 26
UBS ↗
May 20, 25
▲ Buy · 🎯$1350
Price at call : $1186 — upside +14%
Today : $1598.03 — upside -16%
Expected +14% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 0% (1 call matured) · 📊 on Health : 51.7% · +3.1% (358 calls)
-8.7%
stock -9% · XLV +9%
matured May 20, 26
Wells Fargo ↗
May 5, 25
■ Equal-Weight neutral · not a buy · 🎯$1200
Price at call : $1091.13 — gap to target +10%
Today : $1598.03 — gap to target -25%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 5, 26
Jefferies ↗
May 5, 25
■ Hold neutral · not a buy · 🎯$1110
Price at call : $1091.13 — gap to target +2%
Today : $1598.03 — gap to target -31%
🎯 on MTD : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : May 5, 26
Baird ↗
Apr 22, 25
■ Neutral neutral · not a buy · 🎯$1034
Price at call : $1003.16 — gap to target +3%
Today : $1598.03 — gap to target -35%
🎯 on MTD : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 22, 26
Wells Fargo ↗
Apr 17, 25
■ Equal-Weight neutral · not a buy · 🎯$1125
Price at call : $970.15 — gap to target +16%
Today : $1598.03 — gap to target -30%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 17, 26
Citigroup ↗
Apr 7, 25
▲ Buy · 🎯$1400
Price at call : $1032.15 — upside +36%
Today : $1598.03 — upside -12%
Expected +36% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
+23.0%
stock +23% · XLV +9%
matured Apr 7, 26
Citigroup ↗
Mar 4, 25
■ Neutral neutral · not a buy · 🎯$1400
Price at call : $1257.84 — gap to target +11%
Today : $1598.03 — gap to target -12%
🎯 on MTD : 100% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 4, 26
▲ Outperform · 🎯$1475
Price at call : $1331.97 — upside +11%
Today : $1598.03 — upside -8%
Expected +11% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+4.6%
stock +5% · XLV +7%
matured Feb 10, 26
Wells Fargo ↗
Feb 10, 25
■ Equal-Weight neutral · not a buy · 🎯$1400
Price at call : $1331.97 — gap to target +5%
Today : $1598.03 — gap to target -12%
🎯 on MTD : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 10, 26
Baird ↗
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$1369
Price at call : $1340.49 — gap to target +2%
Today : $1598.03 — gap to target -14%
🎯 on MTD : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Feb 10, 26
▲ Outperform · 🎯$1450
Price at call : $1220.78 — upside +19%
Today : $1598.03 — upside -9%
Expected +19% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on MTD : 100% (5 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+15.6%
stock +16% · XLV +13%
matured Jan 2, 26

Frequently asked questions

Should I buy Mettler Toledo stock?

This isn't buy advice. For Mettler Toledo, the analyst consensus is "Hold", with an average price target of $1,508 (-6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Mettler Toledo). We show the numbers — you decide.

Is it too late to buy Mettler Toledo? How high can it go?

The most bullish analyst target on Mettler Toledo is $1,700 (+6% above today's price); the average is $1,508. That's the upside they see. Check how reliable those analysts have actually been on Mettler Toledo on our site before trusting it.

Is Mettler Toledo still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Mettler Toledo, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Mettler Toledo? The case for and against

The arguments for and against, one by one, from the numbers: why invest in MTD (and why hesitate).

What has Mettler Toledo's past performance been?

Historical returns and a "how much if I had invested" calculator: MTD performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)